Article
Cenobamate as add-on treatment for<i>SCN8A</i>developmental and epileptic encephalopathy
2024-10-19
Abstract excerpt
<h4>Objectives</h4> Developmental and epileptic encephalopathies (DEEs) caused by pathogenic variants in SCN8A are associated with difficult-to-treat and early-onset seizures, developmental delay/intellectual disability, impaired quality of life, and increased risk of early mortality. Commonly used antiseizure medications (ASMs) for SCN8A- related disorders, caused by gain-of-function variants, are sodium channel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c87298d8-c7cf-5dff-a4e3-d67475d9479f
- DOI
- 10.1101/2024.10.17.24312949
